Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2

Схожие документы

• Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial
  по: Araki, Kyohei, et al.
  Опубликовано: (2018)
• Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
  по: Miyata, Yasuyoshi, et al.
  Опубликовано: (2020)
• Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
  по: Miyata, Yasuyoshi, et al.
  Опубликовано: (2020)
• Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory Mediators
  по: Yuno, Tsutomu, et al.
  Опубликовано: (2020)
• Recovery from life-threatening pelvic organ prolapse in an 80-year-old Japanese woman: a case report
  по: Matsuo, Tomohiro, et al.
  Опубликовано: (2014)